Replies to post #26336 on Anavex Life Sciences Corp (AVXL)

[blu_1]

I don't comprehend this line of reasoning. If what you say is correct, why'd the study even bother to record amplitudes? And, if a positive change in amplitude does show improvement in cognition in patients with alzheimer's, as Anavex contends, why didn't they use the more reliable ERP measure, which is latency?

[circa1762]

I don't think the latency arguments are a fabrication, but I do think that the new Neuronetrix study makes them look outdated. In the Neuronetrix study, numerous measures of both amplitude and latency achieve statistical significance in discerning between healthy control and mild AD.